НовостиBenzingaStarling Oncology Narrows FY2026 Sales Guidance from $650.000M-$670.000M to $650.000M-$660.000M vs $663.685M Est Starling Oncology Narrows FY2026 Sales Guidance from $650.000M-$670.000M to $650.000M-$660.000M vs $663.685M Est Benzinga 2026.11.05 22:25 (GMT+0) Открыть на Benzinga Другие новости